Harry Gelboin

This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (June 2019) (Learn how and when to remove this message)

Harry V. Gelboin (1929–2010) was an American cancer research scientist, particularly in chemical carcinogenesis. From 1966 to 1999, he was Chief of the Laboratory of Molecular Carcinogenics (now called the Laboratory of Metabolism) at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). His research focused on the activation and detoxification of drugs and carcinogens. He is best known for his studies of the genetic mechanisms by which normal cells transform into malignancy, which constituted a major advance in cancer research.^[1]